Spine surgeon Daniel Park, MD, completed the first U.S. case using Kuros Biosciences’ MagnetOs minimally invasive surgery delivery system, according to an Aug. 5 news release.
MagnetOs MIS, a bone graft delivery system, was cleared by the FDA in May. Compared to a traditional funnel-based system, Magnet OS MIS completed graft placement three times faster.
“MagnetOs MIS delivered smooth, precise graft placement in a typically challenging MIS TLIF case — no preparation, no thawing, just immediate delivery and efficiency,” Dr. Park said in the release. “It pairs streamlined handling with compelling clinical data, making it a meaningful advancement for surgeons who value both efficiency and biologically robust healing.”
A full commercial release is expected for the Fall.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
